Quantcast

Theravance Biopharma doses nOH patients in Phase 3 testing investigational inhibitor ampreloxetine

Theravance Biopharma has started dosing patients with symptomatic neurogenic orthostatic hypotension (nOH) to test its investigational neropinephrine reuptake inhibitor ampreloxetine (TD-9855), in a registrational Phase 3 clinical trial

Read more

Stronger focus on medical applications from Kraiburg

In line with KRAIBURG TPE’s 2019 strategy to increase its focus on medical applications and pharmaceutical packaging, the company recently collaborated with Eastman to develop a range of innovative high-purity TPEs. In close cooperation with Eastman, KRAIBURG TPE has developed a range of THERMOLAST® M thermoplastic elastomers (TPEs) with the capability to adhere directly to specialized polymers used in medical applications, including Eastman’s Tritan™ copolyester, PP, ABS, ABS/PC, and PET.

Read more